Latest News - Celgene

Thursday, October 22, 2015 | Phase 3/4 Trials,, Celgene

Celgene Announces Results From Ongoing Phase 3 LIBERATE Trial of Otezla for Psoriasis

Results from Celgene Corporation’s ongoing Phase 3 LIBERATE trial evaluating Otezla (apremilast) in patients with moderate to severe plaque psoriasis presented at 24th European Academy of Dermat…

Read the full story